Tom Polen argues lean manufacturing is essential for AI success
technology
informative
innovative

Tom Polen argues lean manufacturing is essential for AI success

10
(Update: )
American actor
American business magazine
  • Tom Polen, CEO of Becton Dickinson, emphasizes the importance of lean manufacturing as a precursor to effectively leveraging artificial intelligence.
  • The introduction of BD Excellence in 2024 significantly expanded the application of lean practices within the company.
  • Polen asserts that achieving operational efficiency through lean is crucial for successful AI implementation, and the company's stock performance indicates positive outcomes from these strategies.
Share opinion
1

Story

In the context of the business landscape, the implementation of lean manufacturing principles has garnered significant attention. Tom Polen, who was appointed CEO of Becton Dickinson in 2020, emphasizes the critical role that lean manufacturing plays in enhancing operational efficiency and fostering innovation. As part of his strategic vision, Polen initiated the BD Excellence program in 2024, which aimed to expand lean practices across the organization. This initiative saw a remarkable increase in the number of kaizen projects, growing from just 50 to 1,500 within a year. The CEO contends that the foundation of lean practices is essential for any organization seeking to effectively adopt artificial intelligence technologies. He believes that without a solid groundwork of operational efficiency, the integration of AI will not yield the desired benefits. By first establishing robust systems and processes through lean manufacturing, companies are better positioned to harness the power of AI for enhanced productivity and innovation. In addition to operational benefits, Polen highlights that lean practices have facilitated a cultural shift within the company. Becton Dickinson has undergone significant changes, including the recent spinoff of its bioscience and diagnostic solutions units, which generated $3.3 billion in annual revenue. This strategic focus streamlines the company’s efforts toward its core medical technology business, valued at $18.5 billion. As Becton Dickinson navigates various market challenges, including pricing pressures in China, the company has experienced a 19% increase in its stock price this year, positioning itself favorably against a relatively flat S&P 500 index. Continuous improvement remains a focal point at Becton Dickinson, with initiatives in every promotion, plant visit, and town hall aimed at celebrating behaviors aligned with improvement rather than merely financial performance. The emphasis on fostering a culture of continuous improvement represents a fundamental change in how the company approaches its operational and strategic goals.

2026 All rights reserved